VEGFA and acrocephalopolysyndactyly: Over-expression of vascular endothelial growth factor (VEGF) has been demonstrated in ACPs (42) and positive response to anti VEGF antibody (bevacizumab) as monotherapy and combination with tocilizumab has been reported in recurrent and progressive ACPs (39, 43).